Clinical Trials Sponsored by Bayer

Total 2494 results

LEO Pharma
Bayer

Completed

Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea

Papulopustular Rosacea

United States
LEO Pharma
Bayer

Completed

A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or in the Roof of the Mouth (Cleft Palate) in Newborns and the Use of Glucocorticoids by the Mother During Pregnancy: a Meta-analysis

Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development

Germany
LEO Pharma
Bayer

Completed

21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation

Healthy

United States
LEO Pharma
Bayer

Completed

Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Papulopustular Rosacea

United States
Bayer
Regeneron Pharmaceuticals

Completed

Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied (VENERA)

Glaucoma, Neovascular

Japan
Heidelberg University
Bayer

Withdrawn

Iloprost for Bridging to Heart Transplantation in PH (BRIDGE)

Pulmonary Hypertension | Chronic Left Ventricular Failure

Germany
Bayer
Regeneron Pharmaceuticals

Completed

Study for Collection of Aflibercept Data in Routine Practice (CODEX)

Eye Diseases

France
Bayer
Regeneron Pharmaceuticals

Completed

Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO) (JPMS-CRVO)

Retinal Vein Occlusion

Japan
Regeneron Pharmaceuticals
Bayer

Completed

Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema (RUBY)

Diabetic Macular Edema

United States
Northumbria University
Bayer

Completed

The Effects of Differing Cognitive Task Demands on Whole-body Energy Metabolism and Cerebral Blood-flow: Modulation by Multivitamins/Minerals and Coenzyme Q10

Metabolic Processes

United Kingdom
Bayer
Regeneron Pharmaceuticals

Completed

Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients (VEGA)

Glaucoma, Neovascular

Japan
Bayer
Regeneron Pharmaceuticals

Completed

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada

Diabetic Macular Edema (DME) | Age-related Macular Degeneration (AMD) | Central Retinal Vein Occlusion (CRVO)

Canada
Bayer
Regeneron Pharmaceuticals

Completed

VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)

Macular Degeneration

China
Yale University
Bayer

Completed

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors

Metastatic Breast Cancer | Gastrointestinal Tumors

United States
Regeneron Pharmaceuticals
Bayer

Completed

Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema (VISTA DME)

Diabetic Macular Edema

United States
Bayer
Nektar Therapeutics

Completed

Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia

Pneumonia

United States, France
Columbia University
Bayer

Completed

Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users (WESAIL)

Epilepsy | Contraception

United States
Northwell Health
Bayer

Terminated

Campath Maintenance in Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Regeneron Pharmaceuticals
Bayer

Completed

Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)

Neovascular Age-related Macular Degeneration

United States, Canada
Mahidol University
Bayer

Completed

The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOP

Diffuse Large B-cell Lymphoma

Thailand
Bayer
Regeneron Pharmaceuticals

Completed

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) (VIEW 2)

Macular Degeneration

Belgium, Israel, Italy, Spain, Korea, Republic of, Switzerland, Germany, Portugal, Japan, France, Australia, Netherlands, India, Austria, Brazil, Poland, United Kingdom, Singapore, Hungary, Latvia, Mexico, Czech Republic, Colombia, Ar... and more
Regeneron Pharmaceuticals
Bayer

Completed

Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO) (VIBRANT)

Branch Retinal Vein Occlusion

United States, Japan, Canada
Bayer
Regeneron Pharmaceuticals

Completed

Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) (VIVID-Japan)

Macular Edema

Japan
Bayer
Novartis Pharmaceuticals

Completed

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany
Northwestern University
Bayer

Terminated

Sorafenib-induced Hand- Foot Skin Reaction Treatment

Rash | Hand-foot Skin Reaction

United States
Bayer
Queen's University

Completed

A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis (GEYSER)

Seasonal Allergic Rhinitis

Canada
Emory University
Bayer

Terminated

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab

Lymphoma

United States
Bayer
Nektar Therapeutics

Completed

A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

Pneumonia

France, Spain, United States
UMC Utrecht
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Completed

Vasovist Endoleak Study

Abdominal Aortic Aneurysm

Netherlands
University of Louisville
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Completed

Bayer/Cognitive Assessments With Multiple Sclerosis Subjects

Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remitting

United States
University of Washington
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Terminated

MRI of the Liver With Eovist

Hepatocellular Carcinoma
US Oncology Research
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Terminated

Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX

Colorectal Neoplasms | Adenocarcinoma of the Rectum | Adenocarcinoma of the Colon

United States
NYU Langone Health
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Terminated

Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas

neurofibromatosis1 (NF1) | Recurrent or Progressive Optic Pathway Gliomas (OPG) | Recurrent or Progressive Low-grade Glioma

United States
Institut Claudius Regaud
Bayer

Recruiting

SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer (SUGAR)

Prostate Cancer

France
Asan Medical Center
Bayer

Recruiting

Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation (SPIRIT)

Coronary Artery Disease | Peripheral Arterial Disease | Carotid Stenosis | Atherosclerosis of Artery

Korea, Republic of
Sheba Medical Center
Bayer

Not yet recruiting

Immediate Versus Delayed Initiation of Intrauterine System (JANESS)

Contraception

Israel
University of Utah
Bayer

Completed

Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to Bone (RROPE)

Prostate Cancer Metastatic to Bone

United States
ARCAGY/ GINECO GROUP
Bayer

Completed

REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression (REGOVAR)

Ovarian Carcinoma

France
Ionis Pharmaceuticals, Inc.
Bayer

Completed

A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis (EMERALD)

End-stage Renal Disease (ESRD)

Spain
Hospital do Coracao
Bayer

Active, not recruiting

NEtwork to Control ATherothrombosis (NEAT Registry) (NEAT)

Coronary Artery Disease | Peripheral Arterial Disease | Atherothrombosis

Brazil
Bayer
ICON Clinical Research

Completed

Sorafenib Long Term Extension Program (STEP)

Neoplasms

Spain, Hong Kong, Canada, Germany, France, United States, United Kingdom, Taiwan, New Zealand, Australia, Belgium, China, Bulgaria, Italy, Colombia, Poland, Korea, Republic of, Brazil, Ukraine
University of Rochester
Bayer

Completed

Regorafenib in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
Bayer
SATO PHARMACEUTICAL , Ltd.

Completed

Study on the Safety of the Approved Product Empedic L Cream During Its Routine Use (Active Ingredient is Clotrimazole 1%)

Vaginal Candida

Japan
University Hospital Tuebingen
Bayer

Withdrawn

Reveal Transition - A Mechanistic Study in Transition / Stabilized Phase of CAD (RevealTrans)

Cardiovascular Diseases

Germany
Jena University Hospital
Bayer

Completed

A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers (AD-HERE)

Adherence, Patient | Chronic Eczema

Germany
Bayer
External supplier: HEVA

Completed

A Study Related to the VOYAGER PAD Trial to Learn More About the Target Population for Xarelto in French Patients (PADELTO)

Peripheral Artery Disease

France
Bayer
LMC Diabetes & Endocrinology

Completed

Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D) (AWARE-CKD)

Renal Insufficiency, Chronic

Canada
NSABP Foundation Inc
Bayer

Terminated

A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer (ARGO)

Stage III (IIIB or IIIC) Colon Cancer

United States
Organon and Co
Bayer

Completed

A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

Hypercholesterolemia | Familial Hypercholesterolemia | Homozygous Sitosterolemia
Organon and Co
Bayer

Completed

Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)

Contraception

3

Subscribe